Navigation Links
Echinacea No Cure for the Common Cold, Study Finds
Date:12/21/2010

By Steven Reinberg
HealthDay Reporter

MONDAY, Dec. 20 (HealthDay News) -- The herbal remedy echinacea, believed by many to cure colds, is no better than a placebo in relieving the symptoms or shortening the duration of illness, a new study finds.

"My advice is, if you are an adult and believe in echinacea, it's safe and you might get some placebo effect if nothing else," said lead researcher Dr. Bruce Barrett, an associate professor of medicine at the University of Wisconsin. "I wouldn't say the results of the trial should dissuade people who are currently using echinacea and feel that it works for them, but there is no new evidence to suggest that we have found the cure for the common cold."

If echinacea was able to significantly reduce the symptoms and length of colds, this study would have found it, Barrett noted. "With this particular dose of this particular formulation of echinacea there was no large benefit," he said.

The report is published in the Dec. 21 issue of the Annals of Internal Medicine.

In the study, Barrett's team randomly assigned 719 people with colds to no treatment, to a pill they knew was echinacea, or to a pill that could either be a placebo or echinacea, but they were not told which. The participants ranged from 12 to 80 years of age.

People in the study, which was funded by the U.S. National Center for Complementary and Alternative Medicine (part of the National Institutes of Health), reported their symptoms twice a day for about a week. Among those receiving echinacea, symptoms subsided seven to 10 hours sooner than those receiving placebo or no treatment. This represented a "small beneficial effect in persons with the common cold," according to the study. However, this slight decrease in the duration of their colds was not statistically significant, Barrett said.

There was also no statistically significant difference in the severity of symptoms between the groups, he added.

Douglas "Duffy" MacKay, vice president for scientific and regulatory affairs at the Council for Responsible Nutrition, a lobbying group for the supplement industry, said that "the cure for the common cold has been an elusive target of the medical community for decades. Unfortunately, the best available treatments for this self-limiting condition are modestly effective."

Although this study did not show that echinacea made much of a difference in fighting colds, the study was limited by its size and method of reporting results, MacKay said. "Had a larger sample size been available, it's quite possible the investigators would have observed statistically significant effects," he said.

While the study did not provide evidence that echinacea is the cure for the common cold, the evidence suggests that echinacea use should be "guided by personal health values," MacKay said.

"Consumers can also be reassured by the strong evidence of safety for echinacea," he said. The totality of evidence suggests that echinacea may shorten the duration of a cold while providing moderate symptomatic relief. This magnitude of benefit is comparable to other choices consumers have when grappling with this common and self-limiting condition."

More information

For more information on colds, visit the U.S. National Library of Medicine.

SOURCES: Bruce Barrett M.D., Ph.D., associate professor, medicine, University of Wisconsin, Madison; Douglas "Duffy" MacKay, vice president, scientific and regulatory affairs, Council for Responsible Nutrition; Dec. 21, 2010, Annals of Internal Medicine


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Adapting to clogged airways makes common pathogen resist powerful drugs
2. A common cholesterol drug fights cataracts, too
3. U.S. National Guard Connects Nationwide with Desktop Alert's Command and Control Mass Notification Systems and Common Alerting Protocol (CAP)
4. US21, Inc. is Granted a Wholesale Distributor Permit from the Commonwealth of Virginia Board of Pharmacy
5. New therapeutic target for most common solid cancer in childhood?
6. Migraine More Common in Women with MS
7. Contrast-enhanced MRI could play a key role in differentiating between common types of arthritis
8. Six "Common Sense" Points Not Included In The Health Care Discussion? Should They Be?
9. Six "Common Sense" Points Not Included In The Health Care Discussion? Should They Be?
10. Common osteoporosis drugs are associated with a decrease in risk of breast cancer
11. Commonwealth Leverage Group and Helium Interactive Form HIE Go-To-Market Partnership
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Echinacea No Cure for the Common Cold, Study Finds
(Date:10/13/2017)... ... 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills is proud ... and unique items from across the nation, this holiday-themed event will raise funds and ... the VNA. The boutique will be open Saturday, November 4 (10:00 a.m. – ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released a ... books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture of ... have tossed it off as mere rubbish, but Yisrayl Hawkins says that is because ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a ... “The Journey: From the Mountains to the Mission Field” is the creation of published ... all ages and currently teaches a class of ladies at her church, which she ...
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... Fla. (PRWEB) , ... October 12, 2017 , ... IsoComforter, ... therapy products, announced today the introduction of an innovative new design of the shoulder ... pad so you get maximum comfort while controlling your pain while using cold therapy. ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... EXTON, Pa. , Oct. 12, 2017 ... global leader in innovative solutions for injectable drug administration, ... results before the market opens on Thursday, October 26, ... discuss the results and business expectations at 9:00 a.m. ... 877-930-8295 (U.S.) or 253-336-8738 (International). The conference ID is ...
(Date:10/11/2017)... , Oct. 11, 2017  Hill-Rom Holdings, Inc. ("Hill-Rom") ... Surgical facility in Las Piedras, Puerto Rico ... and blades. ... the facility sustained minor structural damage, temporary loss of ... Repairs have been completed, manufacturing operations have resumed, and ...
(Date:10/5/2017)... 5, 2017  In response to the nationwide ... Maxillofacial Surgeons (AAOMS) released prescribing recommendations that urge ... used as a first-line therapy to manage a ... Recognizing the value and importance ... "Opioid Prescribing: Acute and Postoperative Pain Management" stresses ...
Breaking Medicine Technology: